Resistance to Herpetic Stromal Keratitis in Immunized B-Cell-Deficient Mice  by Daheshia, Massoud et al.
i
i
a
H
o
v
d
l
p
1
F
n
p
s
I
u
t
S
w
T
1
m
m
4
Virology 257, 168–176 (1999)
Article ID viro.1999.9613, available online at http://www.idealibrary.com on
0
C
AResistance to Herpetic Stromal Keratitis in Immunized B-Cell-Deficient Mice1
Massoud Daheshia, Shilpa Deshpande, Sangjun Chun, Nelly A. Kuklin, and Barry T. Rouse2
Department of Microbiology, The University of Tennessee, M409 Walters Life Sciences Building, Knoxville, Tennessee 37996-0845
Received August 4, 1998; returned to author for revision October 23, 1998; accepted January 1, 1999
This study evaluates the role of antibody as an indicator of immunity to ocular challenge with herpes simplex virus (HSV).
Two genotypes of mice, BALB/c or BALB/c with m-chain knockout (mK/O; which lack functional B cells), were immunized
systemically either with nonvirulent infectious virus or with a eukaryotic expression plasmid encoding glycoprotein B (gB).
Whereas naive mK/O mice were 10- to 100-fold more susceptible to HSV infection than BALB/c mice, following immunization
both groups showed similar levels of resistance to ocular challenge. Thus both HSV-immunized groups cleared virus within
3 days and showed no signs of ocular lesions. gB DNA-immunized mice cleared virus less rapidly (5 days), and the incidence
of lesions was 10 and 25% in BALB/c and mK/O mice, respectively. Since mK/O mice failed to produce detectable anti-HSV
antibody, the mechanism of rapid viral removal was assumed to have a T cell basis. However, T cells would likely not mediate
any protection directly since such cells were absent in infected corneas during clearance. A likely mechanism of immunity
could involve innate defenses, perhaps enhanced by the action of cytokines released from antigen-reactive CD41 cells in
vascularized tissue adjacent to the cornea. Thus an abrupt inflammatory response consisting principally of neutrophils
occurred in the corneal stroma in immune mice, and this subsided when virus disappeared. These data reveal that even
though the deficiency in generating antibody renders mice more susceptible to HSV infection, once primed, resistance to
disease expression is mediated solely by the cellular components and their products. © 1999 Academic Press
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fINTRODUCTION
Herpes simplex virus-1 (HSV-1) infection of the cornea,
n susceptible strains of mice, leads to a persistent
mmunoinflammatory lesion called herpetic stromal ker-
titis (HSK) (Rouse, 1996). Athymic mice fail to develop
SK unless reconstituted with CD41 T cells following
cular virus infection (Mercadel et al., 1993). This obser-
ation, along with the nature of principal cytokines found
uring the disease process, has indicated that HSK is a
esion orchestrated mainly by CD41 T cells of the Th1
henotype (Hendricks et al., 1992; Niemialtowski et al.,
992a). Immunized mice usually fail to develop HSK.
urthermore, HSV-immune serum or anti-HSV monoclo-
al antibodies administered systemically up to 3 days
ostinfection may minimize or even prevent the expres-
ion of disease (Lausch et al., 1991; Metcalf et al., 1987).
t is commonly assumed that the reason immunized mice
sually fail to develop ocular lesions upon reinfection is
he presence of neutralizing antibodies in the tear film.
ince the central cornea usually remains avascular,
hich likely precludes the entry of potentially protective
cells into the infected tissues (Doymaz and Rouse,
992), we expected that the outcome of viral challenge in
ice genetically unable to generate anti-HSV antibody
ight differ from events occurring in immunocompetent
1 This work was supported by AI 14981 and EY 05093.
2 To whom reprint requests should be addressed. Fax: (423) 974-f007.
042-6822/99 $30.00
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168ice. In the present report, we compared the outcome of
cular HSV infection in both immunized and naive mK/O
nockout mice (unable to produce antibody) with that in
heir immunocompetent BALB/c counterparts. Mice were
mmunized with either infectious virus or glycoprotein B
gB) DNA, which in H-2d mice fails to induce CD81 T
ells (Manickan et al., 1995), in an attempt to induce a
trong and more modest, respectively, means of immu-
ization.
The results indicate that whereas naive mK/O mice
ere more susceptible to HSV than were BALB/c mice,
mmunization resulted in resistance to lesion expression
nd a similar outcome in terms of duration of viral shed-
ing in both mK/O and BALB/c mice. In gB DNA-immu-
ized animals, BALB/c mice cleared virus more quickly
han mK/O animals but the differences observed were
eager. Our results are discussed in terms of relying on
ntibody as a measure of immune responsiveness to
SV immunogens and the likely mechanisms which op-
rate in the eye to clear virus without pathology in im-
une mice.
RESULTS
mmunization of immunocompetent mice protects
gainst ocular lesions following HSV infection
Infection of the cornea of naive immunocompetent
ALB/c mice with the RE strain of HSV-1 is regularly
ollowed by a CD41 T-cell-orchestrated immunoin-
lammatory lesion in the stroma (Rouse, 1996). This is
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169RESISTANCE TO HSK IN IMMUNIZED MICEalled herpetic stromal keratitis and the equivalent
isease in humans is a common cause of vision im-
airment (Hyndiuk and Glasser, 1986). HSV-immune
ice are known to be protected against HSK following
orneal challenge and the common assumption is that
rotection results primarily from the presence of neu-
ralizing antibody at the infection site (Lausch et al.,
991; Staats et al., 1991). As is shown in Fig. 1, we
onfirm that HSV-immune BALB/c mice are protected
rom lesion development after corneal infection with
SV-1 (RE). Thus whereas almost all control mice
xpressed HSK within 20 days of infection, all HSV-
mmunized and .90% of those immunized intramus-
ularly (im) with gB DNA remained lesion free. Mea-
urement of T cell immunity by the DTH response and
gG antibodies in serum and tears revealed HSV-spe-
ific immunity in both HSV- and gB DNA-immunized
ice at the time of challenge (Table 1).
The presence of antibody in tears at the time of
hallenge led to the expectation that virus would be
eutralized and disappear promptly from the eye fol-
owing challenge. In fact, whereas virus may persist
p to 6 days in some naive BALB/c mice, all HSV-
mmunized animals had cleared ocular virus by 3 days
ostinfection, and gB DNA-immunized mice cleared
cular virus by 5 days. Interestingly, even though im-
une mice had antibody at the time of challenge,
nfectious virus could still be recovered, indicating that
omplete neutralization had not occurred and that
FIG. 1. Immunized BALB/C mice are protected against HSK. BALB/c
ice were immunized at days 0 and 7 with 105 pfu of live HSV-1 (KOS)
r 100 mg of gB DNA or vector DNA. Fifteen days after the first
mmunization, mice were ocularly challenged with 106 pfu of HSV-1
RE). Mice were examined daily for the ocular lesions by two investi-
ators unaware of the experiment, and the severity of lesions was
cored on a 0–5 scale, with 0 corresponding to clear eye and 5 to the
ost severe ocular necrosis. The mean score of HSK is based on three
ndependent experiments including 21 eyes in each group.eplication likely took place. aattern of events in mK/O mice
The availability of mK/O mice on the BALB/c back-
round, which are compromised with respect to the B
ell function (Kitamura et al., 1991), provided an oppor-
unity to further evaluate the role of antibody in ocular
rotection against HSV. However, following im immuni-
ation with 107 plaque-forming units (pfu) of live HSV-1
KOS), a dose well tolerated by naive BALB/c mice, the
ajority of mK/O mice died of encephalitis by 12 days
ostinfection.
In fact, titration of viral susceptibility revealed that
aive mK/O mice were 10–100 times more susceptible
han were BALB/c mice (Table 2). When mK/O mice were
nfected im with 105 pfu of HSV-1 (KOS), almost all ani-
als survived challenge but none developed detectable
erum or ocular antibody responses (Table 3). Neverthe-
ess, immunized mK/O mice developed apparently nor-
al DTH and lymphoproliferation responses to HSV (Ta-
le 3), confirming a normal T cell immune response in
hese mice (Epstein et al., 1995). Following ocular chal-
enge with 106 pfu/ml HSV-1 (10 ID50 for BALB/c), immu-
ized mK/O mice were protected from ocular disease
xpression as well as from encephalitis. On the use of
hree-log higher viral doses a similar pattern of results
as also obtained (data not shown). However, the con-
rol nonimmune mK/O mice developed HSK with a higher
everity and incidence compared to the nonimmune
ALB/c mice upon ocular challenge (Fig. 2). Of particular
nterest, 30% of nonimmune mK/O mice which developed
evere ocular lesions died of encephalitis by day 15
ostinfection compared to the 0% death rate in the
ALB/c control group.
To further evaluate the potential role of antibody in
efining the outcome of HSV ocular challenge, viral titers
n eye swabs collected daily from challenged immune
K/O mice were compared to those collected from im-
TABLE 1
Specific Antibody Responses at Different Sites Following
Intramuscular gB DNA or HSV Immunization of BALB/c Mice
Immunogen
Serum IgG
(ng/ml)
Ocular IgG
(ng/ml)
Ocular IgA
(ng/ml)
DTH
(mm 3 1022)
ector DNA ,100 ,1 ,1 1.2 6 0.3a
B DNA 9,122 6 214 8.1 6 1.0 ,1 7.5 6 1.5b
SV-1 (KOS) 19,326 6 532 22.0 6 7.9 ,1 14.5 6 2.1c
Note. BALB/c mice were immunized with 105 pfu of HSV-1 (KOS) or
00 mg of DNA. Two weeks after the first immunization serum and
cular lavages were individually collected from different groups of
ice. gB-specific antibodies were measured by standard ELISA and
he values from vector DNA- or PBS-immunized mice were subtracted
rom those of the gB DNA- or HSV-1-immunized mice. SD for serum IgG
s based on the average of three independent pool samples. DTH was
easured as the mean difference (mm 3 1022) between the thickness
f left and right ear pinnae in each group at 48 h postchallenge. b vs a,
nd c vs a, P , 0.01.
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170 DAHESHIA ET AL.une BALB/c animals (Table 4). Surprisingly, HSV-immu-
ized mK/O mice appeared to clear virus equally as
ffectively as did immune BALB/c animals. A comparison
f viral titers in swabs from gB-immunized mK/O and
ALB/c mice revealed a minor delay in clearance in
K/O immunized groups but the differences observed
ere small.
hat clears virus from the cornea in the absence of
ntibody?
Since immune mK/O mice mount apparently normal T
ell responses to HSV infection (Table 3), it is reasonable
o assume that clearance of virus from the cornea of
K/O mice is a function of their T cell response. This
ypothesis, however, is difficult to support because the
ormal cornea lacks blood vasculature and inflammatory
ells are absent (Niemialtowski et al., 1992a). Even after
SV infection, T lymphocytes are usually not present in
he now neovascularized cornea until 7–8 days postin-
T
Susceptibility of mK/O Mice to Intramuscular
Dose of virus
mK /O
No. of mice dead/
No. of mice tested
HSV-1 (KOS), 3 3 108 10 /10
HSV-1 (KOS), 107 8 /12
HSV-1 (KOS), 106 5 /12
HSV-1 (KOS), 105 1 /15
Note. Five-week-old naive mK/O or BALB/c mice were infected im wit
f sickness, wasting, paralysis, and encephalitis. Values represent the
a All the BALB/c mice infected with 3 3 108 HSV-1 (KOS) showed the
isease by day 25.
T
Humoral and Cellular Immune Response in mK/O Mice Comp
Mouse Immunogen
Serum IgG (ng
/ml)
Ocular IgG
(ng /ml)
Ocula
(ng /
K/O Vector DNA ,100 ,1 ,1
K/O gB DNA ,100 ,1 ,1
K/O HSV-1 ,100 ,1 ,1
ALB/c Vector DNA ,100 ,1 ,1
ALB/c gB DNA 8,365 6 250 9.2 6 1.2 ,1
ALB/c HSV-1 23,900 6 495 26 6 6.8 ,1
Note. Fifteen days after the first immunization, serum samples or oc
ntibodies were measured in the individual serum or pooled ocular sam
he thickness of the right (105 pfu UV-inactivated HSV-1) and the thickne
plenocyte lymphoproliferation assays were performed as described u
f animals 15 days after the first immunization. Proliferation was record
1 mice.ection (Doymaz and Rouse, 1992). As was observed
erein, viral clearance from the cornea occurred within 3
ays of challenge and no macroscopic evidence of in-
lammatory reactions was evident at that time nor over
he ensuing 20 days after which experiments were usu-
lly terminated.
To further assess the possible role of other cellular
omponents in mediating viral clearance, immune and
aive BALB/c and mK/O mice were challenged via the
ornea with HSV-1 (RE) and at intervals thereafter (1, 2,
nd 9 days) were killed and their corneas collected for
istological and immunohistochemical evaluation. In
one of the groups examined at the 1-day (Fig. 3) and
-day (data not shown) intervals was it possible to detect
lymphocytes in the corneal stroma. However, in the
-day samples taken both from BALB/c and from mK/O
aive mice, such cells were present as part of their early
SK lesions (Fig. 4). Interestingly, as observed previously
ith naive mice (Thomas et al., 1997; Tumpey et al.,
(KOS) Infection Compared to BALB/c Mice
BALB /c
f death
No. of mice dead/
No. of mice tested % of death
00% 0/15a 0%
6.6% 0/10 0%
1% ND
.3% 0/10 0%
ent doses of live HSV-1 (KOS). Mice were examined daily for the signs
btained at day 12 postinfection over which no death was observed.
igns of paralysis at day 7. However, these animals recovered from the
BALB/c Mice Following im gB DNA or HSV-1 Immunization
DTH
(mm 3 1022)
Lymphoproliferation (cpm)
HSV-infected
stimulators
Uninfected
stimulators
ConA
stimulation
1.2 6 0.1 95 6 30 80 6 25 9,700 6 1,500
7.2 6 0.3 ND ND ND
13.3 6 0.4 3420 6 410 120 6 20 8,500 6 1,100
1.5 6 0.4 140 6 50 90 6 30 11,000 6 2,500
8.1 6 0.6 ND ND ND
12.7 6 0.5 4210 6 650 150 6 40 9,300 6 980
vages were collected from individual mice in each group. gB-specific
TH analyses are expressed as mean differences (mm 3 1022) between
e left (Vero extracted) ear pinnae in each group at 48 h postchallenge.
aterials and Methods using the responder cells from different groups
pm. SD is based on the three independent experiments including 7 toABLE 2
HSV-1
% o
1
6
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171RESISTANCE TO HSK IN IMMUNIZED MICE996), following ocular infection of immune animals a
ronounced neutrophil response was encountered in the
enter of the cornea 1 to 2 days postinfection in both
K/O and BALB/c mice. However, the inflammatory re-
ponse was cleared in 9-day samples from both sets of
mmune animals. We presume the PMN or perhaps
ome other component of the innate immune response
uch as the NK cells or soluble factors such as IFN could
ccount for the viral clearance from avascular ocular
issues. We observed similar responses in both naive
K/O and BALB/c animals. Unexpectedly, neutrophil in-
asion also occurred within 24 h in both immune BALB/c
nd mK/O mice but such responses had almost totally
FIG. 2. Immunized mK/O mice are protected against HSK. Fifteen day
NA or vector DNA, mice were ocularly challenged with 106 pfu of HSV
f ocular lesions and the severity of disease was scored from 0 to 5, w
he mean score of HSK is based on three independent experiments inc
SK following ocular challenge and 30% of these mice died of encepha
ecrosis by day 20 with 0% death rate. In both sets of mice, at each po
as ,0.05. For vector-immunized mK/O and vector-immunized BALB/c
T
Virus Titersa on Ocular Surface in DNA or HSV-Immuni
Immunogen Day 1 Day 2 Day 3
ALB/c mice
Vector DNA 5.3 (7/7) 4.4 (7/7) 3.9 (7/
gB DNA 4.4 (7/7) 4.5 (7/7) 2.3 (6/
HSV-1 (KOS) 4.6 (7/7) 2.2 (5/7) 0.3 (1/
K/O mice
Vector DNA 5.2 (5/5) 4.5 (5/5) 3.5 (5/
gB DNA 4.2 (5/5) 4.3 (5/5) 3.3 (5/
HSV-1 KOS 3.4 (5/5) 3.1 (5/5) 0.8 (1/
Note. Different groups of immunized mice were infected on the corne
rom each individual animal, placed in 500 ml of assay medium and tita Viral titers are expressed in log pfu/ml. The numbers in parentheses represolved in both groups by 9 days. Although the cellular
esponse was not quantitated in histological sections,
he neutrophil response in immune mice appeared just
s intense as in naive animals.
DISCUSSION
In this study we evaluated the role of humoral immu-
ity in providing protection against challenge of the cor-
eal surface with HSV. It is commonly assumed that
revention of viral invasion or removal of virus from the
vascular cornea is largely a function of neutralizing or
psonizing antibody (Metcalf et al., 1987). Indeed, some
the first immunization with 105 pfu of live HSV-1 (KOS) or 100 mg of gB
Individual mice in each group were examined daily for the expression
rresponding to a clear eye and 5 to the most severe ocular necrosis.
30 eyes in each group. All the vector-immunized mK/O mice developed
day 15. 90% of the vector-immunized BALB/c mice showed the ocular
P value between vector and gB DNA or HSV-1 (KOS) immunized mice
.01, and for gB-immunized BALB/c and mK/O mice, P , 0.05.
LB/c and mK/O Mice Following Corneal HSV Infection
Day 4 Day 5 Day 6 Day 8
4.3 (7/7) 4.5 (7/7) 2.5 (5/7) 0 (0/7)
1.5 (3/7) 0.9 (3/7) 0.0 (0/7) ND
0.0 (0/7) 0.0 (0/7) 0.0 (0/7) ND
3.3 (5/5) 4.5 (5/5) 3.6 (5/5) 0.0 (0/5)
3.5 (5/5) 2.9 (5/5) 0.0 (0/5) 0.0 (0/5)
0/0 (0/5) 0/0 (0/5) ND ND
06 pfu of HSV-1 (RE). Tear films were collected on sterile cotton swabs
or infectious virus by standard plaque assay.s after
-1 (RE).
ith 0 co
luding
litis by
int, theABLE 4
zed BA
7)
7)
7)
5)
5)
5)
a with 1
rated fesent the number of eyes positive for virus/number of eyes tested.
i172 DAHESHIA ET AL.FIG. 3. Histologic evaluation of ocular sections obtained from nonimmune and immune (HSV) mK/O or BALB/c mice following HSV-1 (RE) corneal
nfection at day 1 or day 9 postinfection (original magnification 3125). Sections were stained with hematoxylin and eosin. (A and B) Sections from
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173RESISTANCE TO HSK IN IMMUNIZED MICEnvestigations had already shown that passive transfer of
SV-specific monoclonals may affect the clinical out-
ome of ocular challenge (Lausch et al., 1991). Conse-
uently, it came as a surprise that following ocular chal-
enge both immunocompetent BALB/c mice and humoral
mmune-deficient mK/O mice showed comparable levels
f resistance. Two forms of immunization were used.
ollowing systemic vaccination with HSV, a potent im-
une stimulus, the rates of viral clearance in both
ALB/c and mK/O mice were identical. A minor delay in
iral clearance was noted in mK/O mice immunized with
B DNA but this might be explained on the basis that gB
NA is a weak immunogen in comparison to HSV (KOS)
Manickan et al., 1995). The absence of the CD8 T cell
esponse could account for the minor differences ob-
erved in the gB DNA-immunized BALB/c and mK/O
ice.
Our data, therefore, accord with the view that anti-HSV
ntibody is an unnecessary resistance mechanism for
urface infection by HSV. The data also indicate that
valuating anti-HSV vaccines based on the level of anti-
odies induced may be an unreliable procedure.
Our observation that HSV-immune mice genetically
ncapable of generating antibody cleared virus just as
ffectively as did immunocompetent animals was unex-
ected. The cornea is a largely avascular structure which
n the unperturbed state lacks inflammatory cells and
ew if any antigen-presenting cells (Niemialtowski et al.,
992a). It is uncommon to find lymphocytes in the central
ornea until several days after HSV infection (Babu et al.,
995). This is likely because time is needed to generate
n immune response and lymphocyte invasion of the
ornea can occur only after angiogenesis. Accordingly, it
emains doubtful if ocular clearance was directly medi-
ted by immune lymphocytes in the immunized mice.
ndeed, we were unable to demonstrate such cells in the
enter of cornea of HSV-challenged immune mice. Fur-
hermore, immune mice failed to develop the immunoin-
lammatory lesion associated with HSV infection which
ccurs in both naive immunocompetent and mK/O mice
uring the second week after infection.
The intriguing question remains as to the mechanism
y which immune animals clear virus more rapidly if
ntiviral antibody is not involved. In naive animals, fol-
owing HSV infection of the cornea, a prompt invasion by
MN occurs in the underlying stroma. Since PMN sup-
ression delays viral clearance in naive mice (Thomas et
l., 1997; Tumpey et al., 1996), PMN are assumed to be
nvolved in antiviral effects. Support for such an idea was
lso provided by in vitro data from the Hendricks labo-
onimmune BALB/c mice on days 1 and 9 postinfection, respectively.
onimmune mK/O mice, HSV-infected eyes on days 1 and 9 postinfect
postinfection. Note that the inflammatory cells in the corneas of ionimmune mice and that there are almost no inflammatory cells in the cornatory (Tumpey et al., 1996). A rapid inflammatory cell
nvasion, principally PMN, also occurred in immune an-
mals. This response persisted for a shorter duration
han that occurring in naive animals and viral clearance
roceeded more rapidly (by 3 days). Conceivably, neu-
rophils, or perhaps some other cell type in the inflam-
atory infiltrate such as macrophages, NK cells, or T
ells, might exert a more effective antiviral function in
mmune animals. A likely explanation could be activation
y T-cell-induced cytokines generated in vascularized
issues adjacent to the cornea or in the draining lymph
ode. We are currently trying to evaluate such ideas by
easuring the antiviral effects in vitro of ocular inflam-
atory cells from immune and naive mice. An alternative
echanism of viral clearance may involve the direct
ction of some cytokines diffusing into the cornea from
ntigen-stimulated T cells in adjacent tissues such as
he conjunctiva. Candidate cytokines are TNF, IFN, and
L-2. The latter, for example, appear to be abruptly ex-
ressed following HSV infection (Tang et al., 1997). We
re currently measuring cytokine proteins in the corneal
xtract to evaluate their role in antiviral immunity.
Whereas both immune BALB/c and mKO mice
howed similar resistance to HSV challenge, this was
ot the case in ocularly challenged naive animals.
hus, mK/O mice were markedly more susceptible to
SV infection and succumbed to encephalitis at virus
oses well tolerated by BALB/c mice. At lower viral
ose of infection, mK/O mice survived and developed
SK just like BALB/c mice. In fact HSK could be
nduced in mK/O mice with lower infectious doses of
irus than were necessary to cause HSK in BALB/c.
nhanced susceptibility to infection in mK/O mice was
lso noted for influenza virus (Graham and Braciale,
997). Although an explanation for susceptibility needs
o be made, we are currently pursuing the idea that
K/O mice have diminished innate immunity. The
plenic and lymphoid tissues in mK/O are less abun-
ant. However, it remains to be shown how the ab-
ence of the ability to produce antibody is related to
he putative deficiencies in innate defenses.
MATERIALS AND METHODS
ice
BALB/c mice (3 to 4 weeks of age) were purchased
rom Harlan Sprague–Dawley (Indianapolis, IN). Immu-
oglobulin m-chain knockout mice (mK/O) were provided
y Dr. Werner Muller (Institute for Genetics, University of
ologne, Germany) (Kitamura et al., 1991). mK/O mice
D) Sections from immune BALB/c mice on days 1 and 9. (E and F)
pectively. (G and H) Sections from immune mK/O mice on days 1 and
mice at day 1 postinfection are at least as numerous as those in(C and
ion, res
mmuneeas of immune mice at day 9 postinfection.
(
m
c
r
O
d
p
9 mice
174 DAHESHIA ET AL.H-2d background) were bred in our pathogen-free ani-
al facility. The lack of IgM1 B cells in these mice was
FIG. 4. Immunohistochemistry for the presence of CD41 T cells in th
ay 1 or day 9 postinfection (original magnification: A, B, C, E, and F
ostinfection, respectively. (C and D) Nonimmune mK/O corneas on day
postinfection. CD41 T cells are present in the cornea of nonimmuneonfirmed by FACS analysis. The authors adhered to the mesolution by Association for Research in Vision and
phthalmology on the use and care of laboratory ani-
eas of nonimmune or immune HSV-1-infected mK/O or BALB/c mice at
; D, 3400). (A and B) Immune BALB/c corneas on day 1 and day 9
day 9 postinfection. (E and F) Immune mK/O corneas on day 1 and day
at day 9 (arrows).e corn
, 3250
1 andals.
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175RESISTANCE TO HSK IN IMMUNIZED MICEirus
HSV-1 RE and KOS strains were propagated on Vero
ells and assayed for measurement of pfu/ml as de-
cribed previously (Manickan et al., 1995).
lasmid DNA
Plasmid DNA encoding gB DNA of HSV-1 (under the
ontrol of CMV promoter) and the vector plasmid were
urified by polyethylene glycol precipitation, according to
ambrook et al. (1989), with some modification as previ-
usly reported (Dahesia et al., 1997).
mmunization
Four- to five-week-old mice were injected with 50 ml of
BS containing 1 3 105 pfu of HSV-1 (KOS) or 100 mg of
lasmid DNA into the quadriceps muscle. Seven days
ater, the mice were boosted and 8 days later, challenged
cularly.
orneal challenge and clinical observation
For induction of HSK, mice were deeply anesthetized
ith methoxyflurane (Metofane; Pittman-Moore, Monde-
ein, IL). Four microliters of inoculum containing 1 3 106
CID50 HSV-1 (RE) was dropped on the scarified cornea
nd massaged gently using the eyelids. The clinical
everity of HSK was evaluated daily with a slit-lamp
iomicroscope (Kowa Co., Nagoya, Japan), in a masked
ashion, based upon the degree of neovascularization,
loudiness, and opacity of the individual cornea. The
coring system, from 0 to 5, was previously reported
Babu et al., 1995).
ntibody detection by ELISA
Fourteen days after the first immunization, serum was
ollected from individual mice, and gB-specific IgG was
easured by standard enzyme-linked immunosorbent
ssay (ELISA). Tears were collected by washing the eye
f individual mice with 20 ml of sterile PBS, on two
ifferent days, using a pipette. Eye washes from 5 to 10
ice were pooled together. gB-specific IgA or IgG were
easured in the eye lavages by ELISA as described
reviously (Kuklin et al., 1997).
irus isolation and titration
Every day after infection, swabs of the corneal surface
ere taken using sterile, medium-soaked cotton-tipped
pplicators from day 1 to day 8. The cotton tip was
laced in 500 ml of DMEM containing 100 mg/ml penicil-
in and 100 mg/ml streptomycin (Life Technology, Inc.)
nd stored at 280°C. Duplicate 200-ml aliquots of each
ample of thawed swab medium were plated on Vero
ells grown to confluence in 24-well plates at 37°C, in 5%
O2 for 1 h and 30 min. Medium was aspirated, and 1 ml wf 23 DMEM containing 1% low-melting-point agarose
as added to each well. Cultures were observed daily
or the development of typical HSV-1 cytopathic effect.
elayed type hypersensitivity
Test antigens were injected into the ear pinna (20 ml
olume) and ear thickness was measured with a screw
auge meter 48 h later. Test antigens included were
V-inactivated HSV-1 (KOS) with a titer of 1 3 105 (before
V inactivation) and Vero cell extract.
ymphoproliferation assay
Two weeks after the first immunization, splenocytes
rom various groups were obtained and individually an-
lyzed for HSV-specific lymphoproliferation. In brief, im-
une splenocytes (responders) were collected and stim-
lated in vitro for 4 days at 37°C with varying ratios of
timulator cells, from BALB/c or mK/O mice, which were
-irradiated naive syngenic splenocytes infected at a
ultiplicity of infection of 1.5 with UV-HSV-1 (KOS). Eigh-
een hours before the harvest, 1 mCi of [3H]TdR was
dded to each well, and harvested cells were measured
or radioactivity.
istopathology
At different times postinfection, mice from each test
roup were sacrificed and whole eyes were fixed in 10%
uffered neutral formalin and embedded in paraffin. Six-
icrometer tissue sections were stained with hematox-
lin and eosin. Presence of inflammatory cells, neovas-
ularization, thickness of the cornea, epithelial erosions,
nd corneal perforation was evaluated from individual
lides.
mmunohistochemistry
Eyes of the immunized and the nonimmunized BALB/c
nd mK/O mice were frozen in OCT compound (Miles,
lkhart, IN) at different days postinfection with 106 pfu of
SV (RE). Six-micrometer-thick sections were cut, air
ried, and fixed in cold acetone (220°C) for 3 min. The
ections were then blocked using 3% BSA and the Avi-
in–Biotin blocking kit (Vector Lab, Inc., Burlingame, CA)
nd stained with purified rat anti-mouse CD4 as primary
ntibody overnight at 4°C ( 1200; Pharmingen) followed by
iotinylated anti-rat Ig ( 150 dilution; Pharmingen) for 1 h at
7°C, followed by addition of peroxidase-conjugated
treptavidin ( 11000 dilution; Jackson Immunoresearch Lab-
ratories, Inc.). The slides were stained by using a liquid
AB staining kit (Biogenex, San Ramon, CA) for 3 min
nd counterstained with hematoxylin for 20 s. Slides
ere coverslipped with Aquamount and examined. As
egative control, irrelevant biotinylated rat Abs and PBS
ere used.
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